Capital Impact Advisors LLC increased its holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 37.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 22,612 shares of the company’s stock after purchasing an additional 6,184 shares during the […]